ReviewCancers2026

Hypomethylating Agents and Venetoclax Based Triplets Targeting FLT3, IDH and KMT2A in Acute Myeloid Leukemia: Current Studies and Challenges of a Tailored Approach.

Elisa Santambrogio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.